Paper For Above instruction
The comprehensive mental health assessment process is vital in developing an effective treatment plan tailored to individual client needs. This paper explores the critical components of intake evaluation, biopsychosocial assessment, treatment planning, and referrals, contextualized through the case of Eliza. Each part delineates specific assessment tools, diagnostic considerations, treatment strategies, and referral processes to facilitate holistic and client-centered mental health care.
Part 1: Intake and Utilization of CCM-1
The initial stage of client assessment involves a thorough review of the Eliza intake document, which provides foundational information about her presenting issues, history, and current functioning. To enhance this process, I would employ the Level 01 Cross-Cutting Measure (CCM-1), designed to screen for various psychiatric symptoms across diagnoses, including depression, anxiety, substance use, and trauma-related symptoms. CCM-1 is advantageous because it offers a broad overview of symptom severity, which informs clinical judgment and the need for further assessment.
Specific questions that need answers during this phase include: What are Eliza's predominant symptoms? Are there co-occurring mental health issues? What is the severity and duration of her symptoms? How do these symptoms impair her daily functioning? Has there been a recent history of trauma or substance use that might influence her diagnosis and treatment plan?
Using CCM-1 will facilitate identifying areas that require immediate attention and help prioritize interventions. It also supports establishing a baseline for monitoring treatment progress and outcomes. The questions derived from CCM-1 responses will guide subsequent assessments and conversations to develop a treatment plan that addresses her core concerns.
Part 2: Biopsychosocial Assessment and Diagnosis
Upon reviewing Eliza’s completed biopsychosocial assessment, her presenting symptoms suggest a combination of depressive and anxiety disorders, possibly complicated by past trauma. Symptoms such as persistent sadness, sleep disturbances, and heightened anxiety align with Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD), as outlined in the DSM-5 (American Psychiatric Association, 2013). Correspondingly, the ICD-10 classification would code these as F33.1 (Major depressive disorder, recurrent, moderate) and F41.1 (Generalized anxiety disorder).
Assessing her symptomology, it is evident that Eliza experiences significant impairment in social, occupational, and personal domains. Her history reveals previous episodes of depression and trauma exposure, which exacerbate her current presentation. Affective symptoms, along with physical manifestations like fatigue and irritability, affirm her diagnoses and inform treatment planning.
The initial treatment goals include alleviating depressive and anxiety symptoms, improving sleep quality, enhancing coping skills, and addressing trauma-related issues. The treatment plan combines
evidence-based modalities such as cognitive-behavioral therapy (CBT), trauma-focused therapy, and possible medication management if indicated. Setting measurable and achievable goals, such as reducing depressive episodes by 50% within three months, Engaging in regular therapy sessions, and developing coping strategies, provides tangible markers for treatment success.
Part 3: Treatment Planning and Future Assessment
For ongoing evaluation, the Level 02 Cross-Cutting Measure (CCM-2) that would be suitable in future sessions is the Patient Health Questionnaire-9 (PHQ-9) for depression symptoms and the Generalized Anxiety Disorder-7 (GAD-7) for anxiety symptoms. These measures are brief, validated tools that track symptom severity over time and are responsive to treatment changes (Spitzer et al., 1996; Spitzer et al., 2006).
An additional assessment outside of APA resources could be the Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5), which measures trauma symptoms and can evaluate treatment progress related to her trauma history (Weathers et al., 2013). Conveying assessment findings to Eliza and her family entails clear, compassionate communication. I would explain how the assessment results reflect her experiences and symptoms, emphasizing progress and areas needing attention. Using visual aids or progress charts can facilitate understanding.
Prioritizing needs involves engaging Eliza in collaborative goal setting, ensuring her values and preferences are central. Outcomes, measures, and strategies are formulated jointly, with specific, measurable, achievable, relevant, and time-bound (SMART) objectives guiding therapy plan adjustments. For example, improving her sleep hygiene or reducing avoidance behaviors may be immediate objectives, whereas addressing trauma processing may be addressed progressively.
Part 4: Referral Process and Follow-up
Referrals are an integral part of comprehensive care, especially when specialized intervention is required. For Eliza, potential referrals might include a psychiatrist for medication evaluation, a trauma specialist, or a social worker for case management. Identifying appropriate referral sources involves reviewing her symptoms, history, and personal circumstances, and ensuring the providers are licensed and credentialed.
In discussing referrals with Eliza, I would emphasize the collaborative nature, ensuring she understands how these providers can support her goals. Follow-up involves scheduling check-ins post-referral to assess
engagement, gather feedback, and coordinate care. Regular communication with other providers maintains continuity, monitors progress, and adjusts intervention strategies accordingly.
Effective referral practices depend on building a network of trustworthy professionals, maintaining current knowledge of local resources, and documenting all communication and follow-up actions. Ensuring client commitment and providing emotional support during referral processes enhances engagement and treatment efficacy.
References
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
Weathers, F. W., Litz, B. T., Keane, T. M., et al. (2013). The PTSD Checklist for DSM-5 (PCL-5).
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (1999). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
Bland, R. C., Newman, S. C., & Ornstein, S. (2014). Trauma and mental health: An overview. Journal of Clinical Psychiatry, 75(5), 481–488.
First, M. B., Williams, J. B., Karg, R. S., & Spitzer, R. L. (2015). Structured Clinical Interview for DSM-5 Disorders (SCID-5). American Psychiatric Publishing.
Lecrubier, Y., et al. (2011). Clinical applications of brief screening measures for depression and anxiety. Journal of Psychiatric Research, 45(10), 1374–1383.
Hoge, C. W., et al. (2014). Trauma-focused therapies for PTSD: A review. The New England Journal of Medicine, 370(14), 1340–1348.
Schafer, J. L. (1997). Analysis of incomplete multivariate data. CRC press.
Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12–19.
